Delonix Bioworks - Crunchbase Company Profile & Funding

Q: Where is Delonix Bioworks's headquarters?

Delonix Bioworks is located in Shanghai, Shanghai, China.

Q: Who invested in Delonix Bioworks?

Delonix Bioworks has 3 investors including Boehringer Ingelheim Venture Fund And ZhenFund.

Q: When was the last funding round for Delonix Bioworks?

Delonix Bioworks closed its last funding round on obfuscated from a Seed round.

Q: How much funding has Delonix Bioworks raised to date?

Delonix Bioworks has raised obfuscated.

Overview

Delonix Bioworks

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+2 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Delonix Bioworks

CB Rank

45638

Delonix Bioworks is working on synthetic biology approaches to develop the next generation medical solutions for infectious diseases.

Founded

obfuscation

Private

Seed

Shanghai, Shanghai, China

51-100

www.delonixbio.com

Biotechnology

Funding Rounds

Seed

OBF

obfuscation

Key People

Qiubin Lin: Chief Executive Officer & Founder

Details

Legal Name

Delonix Bioworks Ltd.

Operating Status

Active

Company Type

For Profit

Founders

Qiubin Lin

About the Company

Delonix Bioworks Ltd. is a synthetic Biology inspired Medicines, they esign and engineer microbial strains rationally to manufacture or as medicines for infectious diseases, cancer and beyond.

Predictions & Insights

Growth Insight

See this Growth Insight

Delonix Bioworks is

Lorem

to be growing

Top Contributing Factors

Operations Expansion

Growth Prediction

See this Growth Prediction

Products & Services

PathX Pathogen Genome Editing Platform

A genome editing platform enabling precise and efficient genetic modifications in over 16 key bacterial pathogens for vaccine development.

OMV Plus Engineered Outer Membrane Vesicle Vaccine Platform

A platform for developing engineered OMV vaccines with scalable production and rational design to improve safety and efficacy.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Delonix Bioworks	3	obfuscated obfuscation	Boehringer Ingelheim Venture Fund, IDG Capital	Seed
obfuscated obfuscation	Seed Round - Delonix Bioworks	3	obfuscated obfuscation	Boehringer Ingelheim Venture Fund, IDG Capital	Seed
obfuscated obfuscation	Seed Round - Delonix Bioworks	3	obfuscated obfuscation	Boehringer Ingelheim Venture Fund, IDG Capital	Seed
obfuscated obfuscation	Seed Round - Delonix Bioworks	3	obfuscated obfuscation	Boehringer Ingelheim Venture Fund, IDG Capital	Seed
obfuscated obfuscation	Seed Round - Delonix Bioworks	3	obfuscated obfuscation	Boehringer Ingelheim Venture Fund, IDG Capital	Seed

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Delonix Bioworks	3	obfuscated obfuscation	Boehringer Ingelheim Venture Fund, IDG Capital	Seed
obfuscated obfuscation	Seed Round - Delonix Bioworks	3	obfuscated obfuscation	Boehringer Ingelheim Venture Fund, IDG Capital	Seed
obfuscated obfuscation	Seed Round - Delonix Bioworks	3	obfuscated obfuscation	Boehringer Ingelheim Venture Fund, IDG Capital	Seed
obfuscated obfuscation	Seed Round - Delonix Bioworks	3	obfuscated obfuscation	Boehringer Ingelheim Venture Fund, IDG Capital	Seed
obfuscated obfuscation	Seed Round - Delonix Bioworks	3	obfuscated obfuscation	Boehringer Ingelheim Venture Fund, IDG Capital	Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Boehringer Ingelheim Venture Fund	Yes	Seed Round - Delonix Bioworks	—
Boehringer Ingelheim Venture Fund	Yes	Seed Round - Delonix Bioworks	—
Boehringer Ingelheim Venture Fund	Yes	Seed Round - Delonix Bioworks	—
Boehringer Ingelheim Venture Fund	Yes	Seed Round - Delonix Bioworks	—
Boehringer Ingelheim Venture Fund	Yes	Seed Round - Delonix Bioworks	—